Long Acting Treatments
Nov 05, 2014
Global Hemophilia Market
Get Market Intelligence of Hemophilia Market with DelveInsight The Haemophilia Market is driven by clotting factor concentrates. Besides hemophilia A and B, and those with von Willebrand disease (VWD), is also sometimes treated with clotting factor. Currently about 20,000 people have hemophilia in the US; about ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
